These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29340326)

  • 1. mTORC1 Inhibition Is an Effective Treatment for Sporadic Renal Angiomyolipoma.
    Pleniceanu O; Omer D; Azaria E; Harari-Steinberg O; Dekel B
    Kidney Int Rep; 2018 Jan; 3(1):155-159. PubMed ID: 29340326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal angiomyolipoma with tuberous sclerosis complex: How it differs from sporadic angiomyolipoma in both management and care.
    Hatano T; Egawa S
    Asian J Surg; 2020 Oct; 43(10):967-972. PubMed ID: 31959574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of gene expression array in TSC2-deficient AML cells reveals IRF7 as a pivotal factor in the Rheb/mTOR pathway.
    Makovski V; Jacob-Hirsch J; Gefen-Dor C; Shai B; Ehrlich M; Rechavi G; Kloog Y
    Cell Death Dis; 2014 Dec; 5(12):e1557. PubMed ID: 25476905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose rapamycin reduces kidney volume angiomyolipomas and prevents the loss of renal function in a patient with tuberous sclerosis complex.
    Peces R; Peces C; Cuesta-López E; Pérez-Dueñas V; Vega-Cabrera C; Azorín S; Selgas R
    Nephrol Dial Transplant; 2010 Nov; 25(11):3787-91. PubMed ID: 20663789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural History of Renal Angiomyolipoma (AML): Most Patients with Large AMLs >4cm Can Be Offered Active Surveillance as an Initial Management Strategy.
    Bhatt JR; Richard PO; Kim NS; Finelli A; Manickavachagam K; Legere L; Evans A; Pei Y; Sykes J; Jhaveri K; Jewett MAS
    Eur Urol; 2016 Jul; 70(1):85-90. PubMed ID: 26873836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial.
    Bissler JJ; Kingswood JC; Radzikowska E; Zonnenberg BA; Frost M; Belousova E; Sauter M; Nonomura N; Brakemeier S; de Vries PJ; Berkowitz N; Miao S; Segal S; Peyrard S; Budde K
    Nephrol Dial Transplant; 2016 Jan; 31(1):111-9. PubMed ID: 26156073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How many surgically-treated angiomyolipomas are related to tuberous sclerosis complex? Insights from a retrospective multicenter study.
    Champy CM; Campi R; Grande P; de la Taille A; Méjean A; Granger B; Bitker MO; Rouprêt M
    Minerva Urol Nefrol; 2020 Apr; 72(2):200-206. PubMed ID: 31619031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial.
    Davies DM; de Vries PJ; Johnson SR; McCartney DL; Cox JA; Serra AL; Watson PC; Howe CJ; Doyle T; Pointon K; Cross JJ; Tattersfield AE; Kingswood JC; Sampson JR
    Clin Cancer Res; 2011 Jun; 17(12):4071-81. PubMed ID: 21525172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent angiomyolipomas and renal cell neoplasms in patients without tuberous sclerosis: a retrospective study.
    Mei M; Rosen LE; Reddy V; Cimbaluk DJ; Gattuso P
    Int J Surg Pathol; 2015 Jun; 23(4):265-70. PubMed ID: 25757955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of cannabidiol on renal angiomyolipoma and subependymal giant cell tumor volume in tuberous sclerosis complex.
    Barnett JR; Grinspoon RA; Harisinghani M; Caruso PA; Thiele EA
    J Clin Neurosci; 2020 Jul; 77():85-88. PubMed ID: 32409220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal angiomyolipoma: clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association.
    Aydin H; Magi-Galluzzi C; Lane BR; Sercia L; Lopez JI; Rini BI; Zhou M
    Am J Surg Pathol; 2009 Feb; 33(2):289-97. PubMed ID: 18852677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unilateral giant renal angiomyolipoma and pulmonary lymphangioleiomyomatosis.
    de Campos FPF; Ferreira CR; Simões AB; de Alcântara PSM; Martines BM; da Silva AF; Azzi-Nogueira D; de Britto LRG; Dufner-Almeida LG; Haddad LA
    Autops Case Rep; 2013; 3(4):53-62. PubMed ID: 28584808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT characteristics predict the response to everolimus or sirolimus of renal angiomyolipomas in patients with tuberous sclerosis complex.
    Wang W; Guo H; Shi B; Sun H; Li H; Zhang Y; Cai Y
    Int Urol Nephrol; 2019 Apr; 51(4):671-676. PubMed ID: 30756282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sporadic versus Tuberous Sclerosis Complex-Associated Angiomyolipomas: Predictors for Long-Term Outcomes following Transcatheter Embolization.
    Sheth RA; Feldman AS; Paul E; Thiele EA; Walker TG
    J Vasc Interv Radiol; 2016 Oct; 27(10):1542-9. PubMed ID: 27522275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic cryoablation of angiomyolipomas in adolescents and young adults: A report of four cases associated with tuberous sclerosis and 1 case of sporadic origin.
    Trelborg K; Nielsen TK; Østraat EØ; Olsen LH
    J Pediatr Urol; 2016 Dec; 12(6):384.e1-384.e6. PubMed ID: 27346068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.
    Bissler JJ; McCormack FX; Young LR; Elwing JM; Chuck G; Leonard JM; Schmithorst VJ; Laor T; Brody AS; Bean J; Salisbury S; Franz DN
    N Engl J Med; 2008 Jan; 358(2):140-51. PubMed ID: 18184959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant hyperactivation of akt and Mammalian target of rapamycin complex 1 signaling in sporadic chordomas.
    Han S; Polizzano C; Nielsen GP; Hornicek FJ; Rosenberg AE; Ramesh V
    Clin Cancer Res; 2009 Mar; 15(6):1940-6. PubMed ID: 19276265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal angiomyolipoma-patient characteristics and treatment with focus on active surveillance.
    Swärd J; Henrikson O; Lyrdal D; Peeker R; Lundstam S
    Scand J Urol; 2020 Apr; 54(2):141-146. PubMed ID: 31971051
    [No Abstract]   [Full Text] [Related]  

  • 19. Living Donor Preemptive Kidney Transplantation in Tuberous Sclerosis Complex Patient and the Role of Mammalian Target of Rapamycin Inhibitor: A Case Report.
    Tarasewicz A; Dębska-Ślizień A; Rutkowska B; Szurowska E
    Transplant Proc; 2020 Oct; 52(8):2520-2523. PubMed ID: 32448667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing disease awareness for tuberous sclerosis complex in patients with radiologic diagnosis of renal angiomyolipoma: an observational study.
    Bausch K; Wetterauer C; Diethelm J; Ebbing J; Boll DT; Dill P; Rentsch CA; Seifert HH
    BMC Nephrol; 2021 Jan; 22(1):47. PubMed ID: 33517888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.